Health Archives - Flint Global

04 Aug, 2026

Burnham bets on social care: implications for operators and investors

Flint Global perspective on Burnham's National Care Service announcements Prime ministers do not usually spend political capital on social care. It is the issue that has ended careers and sunk manifestos (such as Theresa May in 2017) over two decades. The standard move has been to commission a review (e.g. the 2011 Dilnot review) and […]

28 Jul, 2026

What Burnham needs to know about life sciences

Louise Calland Sebastian Culliford

The Life Science Sector Plan's first annual update landed at the end of the political era in which it was written. Work began after Labour's 2024 landslide, when a decade-long framework tied to the Industrial Strategy and 10 Year Health Plan looked capable of surviving at least a full parliament. A year after publication, Keir […]

20 Feb, 2026

Pharmaceuticals as Strategic Assets: Trade, Pricing and Economic Security

James Hedgeland Katie Whitting Sam Lowe

This month has seen the launch of TrumpRx – the US Government’s new direct-to-consumer platform with the stated aim of delivering ‘most favoured nation’ drug prices to the US after decades in which Americans paid much more for its medicines than most of the rest of the world. US drug pricing continues to be a […]

23 Jul, 2025

The Life Sciences Sector Plan: does its inauspicious start doom it to failure?

James Hedgeland Verity Ryan

While long-awaited, the launch of the Life Sciences Sector Plan – the sixth of the Industrial Strategy’s eight-part anthology – passed without fanfare last week. This was in no small part due to ongoing tensions between the sector and the Government over drug pricing negotiations The plan includes 33 actions in total, but of these, […]

22 Aug, 2023

The new workforce and health rationales for a bigger Occupational Health sector

James Hedgeland Verity Ryan

Occupational Health (OH) policy isn’t a topic you traditionally hear politicians discuss. Jointly overseen by the health and welfare departments, it can often struggle to gain traction against more headline-grabbing health and welfare system reforms. This too is reflected in low levels of awareness for OH among politicians, the public, and much of the business […]

05 May, 2023

A step towards a Health Union or a blow to the EU’s competitiveness: stakeholder reactions to the Pharmaceutical Package

Benoit Roussel Quentin Duthilleul

On 26 April, after months of delay, the European Commission published its long-awaited proposed reform of the pharmaceutical legislation. The largest overhaul of the EU’s health legislation in over 20 years, the “Pharma Package” focuses on supporting both drug availability and affordability and investment in health innovation by making pharmaceutical incentives more conditional. Heated debates […]

14 Dec, 2022

Challenge & opportunity – investor and business outlook for the UK health and care sector

James Hedgeland Verity Ryan

Key points What challenges are facing health and care? The challenges facing the new Health Secretary heading into winter are not new: the Covid backlog; strain on emergency, primary and social care; and workforce pressures. However, the wider backdrop has worsened, with strike action by nurses and paramedics planned, and inflationary pressures squeezing existing spending […]

Category: Health

Burnham bets on social care: implications for operators and investors

What Burnham needs to know about life sciences

Pharmaceuticals as Strategic Assets: Trade, Pricing and Economic Security

The Life Sciences Sector Plan: does its inauspicious start doom it to failure?

The new workforce and health rationales for a bigger Occupational Health sector

A step towards a Health Union or a blow to the EU’s competitiveness: stakeholder reactions to the Pharmaceutical Package

Challenge & opportunity – investor and business outlook for the UK health and care sector

Follow us

Quick links

Sectors

Follow Us